Education
About Us
Working with TipRanks
Follow Us
JEPI - ETF AI Analysis
Top Page
JPMorgan Equity Premium Income ETF (JEPI)
Rating:72Outperform
Price Target:―
Positive Factors
Strong Top Holdings
Several of the ETF's largest positions, including Nvidia and Alphabet, have delivered strong year-to-date performance, supporting overall returns.
Sector Diversification
The ETF is spread across multiple sectors like Technology, Health Care, and Financials, reducing reliance on any single industry.
Reasonable Expense Ratio
The fund's expense ratio of 0.35% is relatively low, making it cost-effective compared to many actively managed ETFs.
Negative Factors
High U.S. Concentration
With nearly 99.5% of its holdings in U.S. companies, the ETF lacks global diversification and is sensitive to domestic market conditions.
Mixed Recent Performance
The ETF's year-to-date performance is slightly negative, which may concern investors seeking consistent growth.
Underweight in Growth Sectors
Sectors like Energy and Materials have minimal representation, potentially limiting exposure to growth opportunities in these areas.
JEPI vs. SPDR S&P 500 ETF (SPY)
AUM42.11B
RegionNorth America
Expense Ratio0.35%
Beta0.59
IssuerJPMorgan
Inception DateMay 20, 2020
Dividend Yield8.17%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume4,797,743
30 Day Avg. Volume5,229,007
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
66.16Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering109
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
JEPI Summary
The JPMorgan Equity Premium Income ETF (JEPI) is an investment fund that focuses on large, well-established companies in the U.S., such as Microsoft and Johnson & Johnson. It’s designed to provide both growth potential and monthly income by combining investments in high-quality stocks with a strategy that takes advantage of market fluctuations. This makes it appealing for investors who want steady income alongside exposure to major companies across industries like technology, healthcare, and finance. However, new investors should be aware that JEPI’s performance can be affected by overall market trends, meaning its value may rise or fall with the broader stock market.
How much will it cost me?The JPMorgan Equity Premium Income ETF (JEPI) has an expense ratio of 0.35%, which means you’ll pay $3.50 per year for every $1,000 invested. This expense ratio is slightly higher than average for ETFs because JEPI uses an actively managed strategy combining large-cap stocks with options to generate income. Active management typically involves higher costs due to the complexity of the strategy.
What would affect this ETF?JEPI's focus on large-cap U.S. stocks and income generation through options strategies makes it well-positioned to benefit from a stable or growing economy, especially if technology and healthcare sectors continue to perform strongly. However, rising interest rates or regulatory changes affecting its top holdings, such as Alphabet or Nvidia, could negatively impact its growth potential. Additionally, market volatility could either enhance income opportunities or pose risks to its strategy.
JEPI Top 10 Holdings
JEPI’s portfolio leans heavily into large-cap U.S. stocks, with a notable concentration in technology and healthcare. Alphabet and Ross Stores are rising stars, benefiting from strong earnings and strategic growth, while Microsoft and Amazon are showing mixed signals, with short-term weakness holding them back despite promising long-term prospects in cloud and AI. AbbVie has been lagging, weighed down by valuation concerns despite its strong pipeline. With its blend of steady blue-chip names and income-focused strategy, the fund balances growth potential with a defensive edge, though tech dominance adds a layer of volatility.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Johnson & Johnson | 1.91% | $684.44M | $493.40B | 45.84% | 78 Outperform | |
| Alphabet Class A | 1.90% | $683.89M | $3.79T | 66.01% | 85 Outperform | |
| AbbVie | 1.87% | $672.96M | $395.77B | 30.77% | 66 Neutral | |
| ― | 1.83% | $657.60M | ― | ― | ― | |
| Analog Devices | 1.80% | $648.23M | $143.44B | 32.87% | 78 Outperform | |
| Mastercard | 1.79% | $642.60M | $521.14B | 12.30% | 75 Outperform | |
| Amazon | 1.77% | $634.90M | $2.58T | 8.75% | 71 Outperform | |
| Howmet Aerospace | 1.74% | $623.41M | $86.32B | 83.31% | 67 Neutral | |
| Visa | 1.73% | $622.82M | $683.74B | 13.84% | 70 Outperform | |
| Ross Stores | 1.73% | $621.70M | $60.66B | 20.93% | 80 Outperform |
JEPI Technical Analysis
Positive
―
Price Trends
56.99
Positive
56.45
Positive
55.00
Positive
Market Momentum
0.19
Positive
55.46
Neutral
66.01
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For JEPI, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 57.63, equal to the 50-day MA of 56.99, and equal to the 200-day MA of 55.00, indicating a bullish trend. The MACD of 0.19 indicates Positive momentum. The RSI at 55.46 is Neutral, neither overbought nor oversold. The STOCH value of 66.01 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JEPI.
JEPI Peer Comparison
Comparison Results
Performance Comparison
JEPI
JPMorgan Equity Premium Income ETF
58.04
5.13
9.70%
DFAC
Dimensional U.S. Core Equity 2 ETF
―
―
―
JEPQ
J.P. Morgan Nasdaq Equity Premium Income ETF
―
―
―
DYNF
BlackRock U.S. Equity Factor Rotation ETF
―
―
―
DFUS
Dimensional U.S. Equity ETF
―
―
―
DUHP
Dimensional US High Profitability ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents